The idea of nucleus replacement has been discussed by physicians for at least 20 years. This interest has driven multiple companies to work on developing a long-term implant.
Spinal Tech
Global medical technology SeaSpine has begun the limited commercial launch and completed initial surgeries using its implant system to treat adult spine deformities, the company said Sept. 7.
The CEO and CFO of Malden, Mass.-based SpineFrontier were charged in connection to a kickback scheme in which surgeons were allegedly bribed to use the devicemaker's products in exchange for sham consulting fees, the Department of Justice said Sept. 7.
Zimmer Biomet has set its 2021 third quarter dividend, the company announced Sept. 3.
Orthopedic devicemaker Think Surgical named Stuart Simpson as its new president and CEO, the company said Sept. 1.
NuVasive has created two new executive leadership roles, the company announced Sept. 1.
Acquisitions are abundant within the spine and orthopedic device industry. Here are nine that were completed or announced in the last year that total more than $6 billion:
Bioventus' acquisition activities so far this year total more than $1 billion. Its most recent plans were announced Aug. 30.
From FDA approvals to investments, here are seven updates from spine and orthopedic device companies in the last week:
David Frumberg, MD, performed the first U.S. implantation of Orthofix's Fitbone system in a pediatric patient, according to a Sept. 1 news release.
